It has been shown that an overexpression of histone acetyltransferase (HAT) activator p300, linked to NAFLD progression, determines hyperacetylation of carbohydrate-responsive element-binding protein (ChREBP), promoting its transcriptional activity. The gene discussed is MLXIPL; the disease is metabolic dysfunction-associated steatotic liver disease.